phase readout
saveNCT07480564: Safety and Preliminary Efficacy of TSHA-102 Gene Therapy in Pediatric Females Aged >2 to <4 Years With Rett Syndrome
NOT_YET_RECRUITINGupdated 1mo ago
community read0 votes
Sponsor: Taysha Gene Therapies, Inc.. Phase: PHASE3. Conditions: Rett Syndrome
view source ↗
comments(0)
5-min edit window · permanent after that